Literature DB >> 6171070

Chemical mediators of intraocular neovascularization.

B M Glaser, P A D'Amore, G A Lutty, A H Fenselau, R G Michels, A Patz.   

Abstract

Intraocular neovascularization occurs in several ocular disorders. Evidence from clinical experimental observations suggests that the retina and the vitreous are potential sources of angiogenic stimulators and inhibitors which may play a role in the development of intraocular neonvascularization. We have demonstrated that extracts of adult retina are capable of stimulating vasoproliferation on the chick chorioallantoic membrane (CAM) and that extracts of adult vitreous inhibit this response. In addition, extracts of adult retina are capable of stimulating vascular endothelial cell proliferation and chemotaxis in vitro. The relationship of these findings to human disease is as yet unknown. However, we have found a good correlation between the presence of retinal, optic disc, and/or iris neovascularization in eyes undergoing therapeutic vitrectomy and the ability of intraocular fluid from these eyes (obtained at the time of surgery) to stimulate vasoproliferation on the CAM As well as thymidine uptake of vascular endothelial cells in culture. Further studies will be necessary to determine the relationship of these different findings to human intraocular neovascularization.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6171070

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  4 in total

1.  Isolation and characterization of microvascular endothelial cells from chicken fat pads.

Authors:  W O Twal; R M Leach
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996 Jul-Aug       Impact factor: 2.416

2.  Retinal ischemia and cell proliferation in the rat: the role of soluble mitogens.

Authors:  A Ohira; E Stefansson; E de Juan; R C Davidson; N Faberowski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 3.  Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept.

Authors:  João Rafael de Oliveira Dias; Gabriel Costa de Andrade; Eduardo Amorim Novais; Michel Eid Farah; Eduardo Büchele Rodrigues
Journal:  Int J Retina Vitreous       Date:  2016-02-01

4.  VEGF: From Discovery to Therapy: The Champalimaud Award Lecture.

Authors:  Joan W Miller
Journal:  Transl Vis Sci Technol       Date:  2016-03-11       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.